- Previous Close
70.00 - Open
73.50 - Bid 69.50 x --
- Ask 73.00 x --
- Day's Range
70.10 - 73.50 - 52 Week Range
61.20 - 92.00 - Volume
14,000 - Avg. Volume
85,855 - Market Cap (intraday)
3.15B - Beta (5Y Monthly) -0.39
- PE Ratio (TTM)
39.60 - EPS (TTM)
1.77 - Earnings Date --
- Forward Dividend & Yield 1.50 (2.05%)
- Ex-Dividend Date Jun 21, 2024
- 1y Target Est
--
Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials, and products in Taiwan. The company offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamin, anti-inflammatory, cough and cold, pain reliever, etc. It provides its products in the solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. Johnson Chemical Pharmaceutical Works Co., Ltd. was incorporated in 1959 and is based in New Taipei City, Taiwan.
www.jcpjohnson.com.tw167
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 4747.TWO
View MorePerformance Overview: 4747.TWO
Trailing total returns as of 11/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4747.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4747.TWO
View MoreValuation Measures
Market Cap
3.15B
Enterprise Value
2.24B
Trailing P/E
39.55
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.27
Price/Book (mrq)
1.87
Enterprise Value/Revenue
3.62
Enterprise Value/EBITDA
17.09
Financial Highlights
Profitability and Income Statement
Profit Margin
12.63%
Return on Assets (ttm)
3.28%
Return on Equity (ttm)
6.06%
Revenue (ttm)
616.34M
Net Income Avi to Common (ttm)
77.82M
Diluted EPS (ttm)
1.77
Balance Sheet and Cash Flow
Total Cash (mrq)
1.11B
Total Debt/Equity (mrq)
8.99%
Levered Free Cash Flow (ttm)
66.09M